221 related articles for article (PubMed ID: 19230787)
1. The management of inoperable Stage I endometrial cancer using intracavitary brachytherapy alone: a 20-year institutional review.
Shenfield CB; Pearcey RG; Ghosh S; Dundas GS
Brachytherapy; 2009; 8(3):278-83. PubMed ID: 19230787
[TBL] [Abstract][Full Text] [Related]
2. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
[TBL] [Abstract][Full Text] [Related]
3. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
4. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
5. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
6. Treatment of endometrial carcinoma with high-dose-rate brachytherapy alone in medically inoperable stage I patients.
Kucera H; Knocke TH; Kucera E; Pötter R
Acta Obstet Gynecol Scand; 1998 Nov; 77(10):1008-12. PubMed ID: 9849846
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma.
Niazi TM; Souhami L; Portelance L; Bahoric B; Gilbert L; Stanimir G
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1108-13. PubMed ID: 16099598
[TBL] [Abstract][Full Text] [Related]
8. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer].
Lei X; Shan JL; Tang C; Zhao KW
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
[TBL] [Abstract][Full Text] [Related]
10. Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer.
Jereczek-Fossa BA; Badzio A; Jassem J
Radiother Oncol; 2004 Aug; 72(2):175-81. PubMed ID: 15297136
[TBL] [Abstract][Full Text] [Related]
11. Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?
Crosby MA; Tward JD; Szabo A; Lee CM; Gaffney DK
Am J Clin Oncol; 2010 Aug; 33(4):364-9. PubMed ID: 20689365
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate brachytherapy for medically inoperable stage I endometrial cancer.
Nguyen TV; Petereit DG
Gynecol Oncol; 1998 Nov; 71(2):196-203. PubMed ID: 9826460
[TBL] [Abstract][Full Text] [Related]
13. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma.
Fayed A; Mutch DG; Rader JS; Gibb RK; Powell MA; Wright JD; Elnaqa I; Zoberi I; Grigsby PW
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):480-4. PubMed ID: 17141980
[TBL] [Abstract][Full Text] [Related]
14. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer.
Jolly S; Vargas C; Kumar T; Weiner S; Brabbins D; Chen P; Floyd W; Martinez AA
Gynecol Oncol; 2005 Jun; 97(3):887-92. PubMed ID: 15943991
[TBL] [Abstract][Full Text] [Related]
15. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.
Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G
Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150
[TBL] [Abstract][Full Text] [Related]
16. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
[TBL] [Abstract][Full Text] [Related]
17. Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer.
Martínez-Monge R; Nagore G; Cambeiro M; Garrán C; Villafranca E; Jurado M
Brachytherapy; 2007; 6(3):195-200. PubMed ID: 17681240
[TBL] [Abstract][Full Text] [Related]
18. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
19. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients.
Röper B; Astner ST; Heydemann-Obradovic A; Thamm R; Jacob V; Hölzel D; Schmalfeldt B; Kiechle-Bahat M; Höss C; Molls M
Gynecol Oncol; 2007 Dec; 107(3):541-8. PubMed ID: 17884152
[TBL] [Abstract][Full Text] [Related]
20. Endometrial adenocarcinoma: an analysis of treatment and outcome.
Byrd LM; Swindell R; Webber-Rookes D; Hannon R; Hunter RD; Livsey J; Davidson SE
Oncol Rep; 2008 Nov; 20(5):1221-8. PubMed ID: 18949425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]